STANDARD BIOTOOLS INC.LABEarnings & Financial Report
Nasdaq · Health Care · Laboratory Analytical Instruments
Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| NOS. OF ABOVE PERSONS | 18.59% | 69.0M | ▲ +1.30pp | 2024-08-14 |
| Viking Global Investors LP | 15.30% | 58.7M | ▲ +5.80pp | 2024-03-20 |
| BlackRock, Inc. | 6.00% | 22.5M | flat | 2024-11-08 |
| The Vanguard Group | 4.65% | 17.3M | flat | 2024-11-12 |
| Caligan Partners LP | 2.40% | 7.0M | — | 2024-01-08 |
| Millennium Management LLC | 1.90% | 7.0M | ▼ -3.30pp | 2024-10-21 |
| Indaba Capital Management, L.P. | 0.70% | 2.6M | ▼ -9.20pp | 2024-11-14 |
| s/ | — | 4.4M | — | 2024-01-12 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-06 | Michael Egholm | President & CEO | Option exercise | 196.5K | $0.00 | $0 |
| 2026-04-06 | Kim Hanjoon Alex | Chief Financial Officer | Option exercise | 70.2K | $0.00 | $0 |
| 2026-03-20 | Michael Egholm | President & CEO | Grant | 1.04M | $0.00 | $0 |
| 2026-03-20 | Kim Hanjoon Alex | Chief Financial Officer | Grant | 323.2K | $0.00 | $0 |
| 2026-03-20 | Sean Mackay | SVP & Chief Business Officer | Grant | 272.1K | $0.00 | $0 |
| 2026-02-26 | Carey Thomas D. | Director | Grant | 51.3K | $1.17 | $60.0K |
| 2026-02-26 | Eli Casdin | Director | Grant | 53.0K | $1.17 | $62.0K |
| 2026-02-26 | Troy Cox | Director | Grant | 57.3K | $1.17 | $67.0K |
1–8 of 8